Lymphatic disorders caused by mosaic, activating KRAS variants respond to MEK inhibitionSarah E. Sheppard, Håkon Håkonarson, Michael March et al.|JCI Insight|2023Cited by 37
0798 Low-grade spitz melanocytoma with novel PTMA: ALK fusionRebecca Fliorent, Ata S. Moshiri, George Jour et al.|Journal of Investigative Dermatology|2025Cited by 0